These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 26930122)

  • 1. Vascular Endothelial Growth Factor and Podocyte Protection in Chronic Hypoxia: Effects of Endothelin-A Receptor Antagonism.
    Harvey TW; Engel JE; Chade AR
    Am J Nephrol; 2016; 43(2):74-84. PubMed ID: 26930122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic blockade of endothelin A and B receptors using macitentan in experimental renovascular disease.
    Tullos NA; Stewart NJ; Davidovich R; Chade AR
    Nephrol Dial Transplant; 2015 Apr; 30(4):584-93. PubMed ID: 25438341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin-1 cooperates with hypoxia to induce vascular-like structures through vascular endothelial growth factor-C, -D and -A in lymphatic endothelial cells.
    Garrafa E; Caprara V; Di Castro V; Rosanò L; Bagnato A; Spinella F
    Life Sci; 2012 Oct; 91(13-14):638-43. PubMed ID: 22552325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast growth factor and endothelin-1 receptors mediate the response of human striatal precursor cells to hypoxia.
    Ambrosini S; Sarchielli E; Comeglio P; Porfirio B; Gallina P; Morelli A; Vannelli GB
    Neuroscience; 2015 Mar; 289():123-33. PubMed ID: 25595970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelin receptor-A mediates degradation of the glomerular endothelial surface layer via pathologic crosstalk between activated podocytes and glomerular endothelial cells.
    Ebefors K; Wiener RJ; Yu L; Azeloglu EU; Yi Z; Jia F; Zhang W; Baron MH; He JC; Haraldsson B; Daehn I
    Kidney Int; 2019 Oct; 96(4):957-970. PubMed ID: 31402170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual endothelin receptor antagonists contrast the effects induced by endothelin-1 on cultured human microvascular endothelial cells.
    Soldano S; Paolino S; Pizzorni C; Trombetta AC; Montagna P; Brizzolara R; Corallo C; Giordano N; Sulli A; Cutolo M
    Clin Exp Rheumatol; 2017; 35(3):484-493. PubMed ID: 28134077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin B receptor deficiency predisposes to pulmonary edema formation via increased lung vascular endothelial cell growth factor expression.
    Carpenter T; Schomberg S; Steudel W; Ozimek J; Colvin K; Stenmark K; Ivy DD
    Circ Res; 2003 Sep; 93(5):456-63. PubMed ID: 12919946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous endothelin in human coronary vascular function: differential contribution of endothelin receptor types A and B.
    Halcox JP; Nour KR; Zalos G; Quyyumi AA
    Hypertension; 2007 May; 49(5):1134-41. PubMed ID: 17353514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of endothelin-1 and its receptors, ET
    Mikhail M; Vachon PH; D'Orléans-Juste P; Jacques D; Bkaily G
    Can J Physiol Pharmacol; 2017 Oct; 95(10):1298-1305. PubMed ID: 28732172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The balance of autocrine VEGF-A and VEGF-C determines podocyte survival.
    Müller-Deile J; Worthmann K; Saleem M; Tossidou I; Haller H; Schiffer M
    Am J Physiol Renal Physiol; 2009 Dec; 297(6):F1656-67. PubMed ID: 19828679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin-A receptor blockade slows the progression of renal injury in experimental renovascular disease.
    Kelsen S; Hall JE; Chade AR
    Am J Physiol Renal Physiol; 2011 Jul; 301(1):F218-25. PubMed ID: 21478482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autocrine VEGF-A system in podocytes regulates podocin and its interaction with CD2AP.
    Guan F; Villegas G; Teichman J; Mundel P; Tufro A
    Am J Physiol Renal Physiol; 2006 Aug; 291(2):F422-8. PubMed ID: 16597608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective ETA vs. dual ETA/B receptor blockade for the prevention of sunitinib-induced hypertension and albuminuria in WKY rats.
    Mirabito Colafella KM; Neves KB; Montezano AC; Garrelds IM; van Veghel R; de Vries R; Uijl E; Baelde HJ; van den Meiracker AH; Touyz RM; Danser AHJ; Versmissen J
    Cardiovasc Res; 2020 Aug; 116(10):1779-1790. PubMed ID: 31593221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelin receptors in augmented vasoconstrictor responses to endothelin-1 in chronic intermittent hypoxia.
    Guo QH; Tian YL; Wang Z; Li AY; Ma ZH; Guo YJ; Weiss JW; Ji ES; Chu L
    Clin Exp Pharmacol Physiol; 2013 Jul; 40(7):449-57. PubMed ID: 23662699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the endothelin axis in human melanoma: combination of endothelin receptor antagonism and alkylating agents.
    Berger Y; Bernasconi CC; Juillerat-Jeanneret L
    Exp Biol Med (Maywood); 2006 Jun; 231(6):1111-9. PubMed ID: 16741059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular Effects of Endothelin Receptor Antagonists Depends on Their Selectivity for ETA Versus ETB Receptors and on the Functionality of Endothelial ETB Receptors.
    Iglarz M; Steiner P; Wanner D; Rey M; Hess P; Clozel M
    J Cardiovasc Pharmacol; 2015 Oct; 66(4):332-7. PubMed ID: 25992919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From placenta to podocyte: vascular and podocyte pathophysiology in preeclampsia.
    Wagner SJ; Craici IM; Grande JP; Garovic VD
    Clin Nephrol; 2012 Sep; 78(3):241-9. PubMed ID: 22874114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late-onset endothelin-A receptor blockade reduces podocyte injury in homozygous Ren-2 rats despite severe hypertension.
    Opocenský M; Kramer HJ; Bäcker A; Vernerová Z; Eis V; Cervenka L; Certíková Chábová V; Tesar V; Vanecková I
    Hypertension; 2006 Nov; 48(5):965-71. PubMed ID: 17015777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-β regulates endothelin-1 signaling in the newborn mouse lung during hypoxia exposure.
    Olave N; Nicola T; Zhang W; Bulger A; James M; Oparil S; Chen YF; Ambalavanan N
    Am J Physiol Lung Cell Mol Physiol; 2012 May; 302(9):L857-65. PubMed ID: 22287612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelin inhibits cholangiocarcinoma growth by a decrease in the vascular endothelial growth factor expression.
    Fava G; Demorrow S; Gaudio E; Franchitto A; Onori P; Carpino G; Glaser S; Francis H; Coufal M; Marucci L; Alvaro D; Marzioni M; Horst T; Mancinelli R; Benedetti A; Alpini G
    Liver Int; 2009 Aug; 29(7):1031-42. PubMed ID: 19291182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.